5 steps to close the marijuana industry’s C-suite gender gap

Published

2 years ago

March 20, 2023

admin

Sarah Bodnar

This column is part of a series during Women’s History Month that offers practical steps toward elevating women in cannabis. The previous installment is available here.

In an industry that once had an unusually high percentage of female CEOs, the marijuana sector now has fewer women in leadership positions than the U.S. average.

According to MJBizDaily’s 2022 report, “Diversity, Equity & Inclusion in the Cannabis Industry,” the percentage of women executives in cannabis fell from 36.8% in 2019 to 23.1% last year.

Meanwhile, the Russell 3000 index of publicly traded companies reports that women now hold 28% of board seats of the 3,000 largest U.S. stocks it tracks.

How did we get here?

Summer Westerbur

In general, power is a self-fulfilling prophecy.

Statistically, white men have disproportionate access to capital and connections. And capital opens doors.

More opportunity equals more power. Having more women in leadership positions will, too.

Read full article on Marijuana Business Daily

Source link

Trump research cuts threaten cannabis studies, poses rescheduling questions

Published

11 hours ago

February 27, 2025

admin

The Trump administration’s plan to cut federal research funding threatens 565 ongoing experiments involving cannabis, according to an MJBizDaily review and interviews with scientists and academics.

An accompanying freeze of new National Institutes of Health (NIH) grants is also stymieing future research at a key moment – and raising questions about the fate of marijuana rescheduling as well as suggesting profound consequences for the regulated MJ industry.

The NIH announced Feb. 7 that it would drastically reduce to no more than 15% the amount of “indirect costs” – money used to cover administrative and facility-related bills – financed by federal research grants.

Without fully funded indirect costs, “I literally cannot do my research,” Angela Bryan, a professor of psychology and neuroscience at the

Read full article on Marijuana Business Daily

Source link

Marijuana Business Daily

Medical cannabis registries show steep decline after launch of adult-use sales

Published

2 days ago

February 25, 2025

admin

(This is the first installment in a series – a collaboration with the Marijuana Policy Project – highlighting demographic shifts within medical cannabis registries nationwide.)

The expansion of adult-use marijuana sales to 21 states has ushered in a new era of commercialism in the U.S. cannabis industry.

For some retailers, that means a concentration of certain well-performing products.

For some medical marijuana patients, that means less access to full-spectrum cannabis stock-keeping units (SKUs).

Inventory rightsizing is a key element for retail success, particularly given the dramatic shifts in customer and product demand after a market’s conversion to recreational sales.

“In most adult-use legalization states, the number of registered patients has dropped significantly since legalization passed,” Karen O’Keefe, director of state policies for the

Read full article on Marijuana Business Daily

Source link

Marijuana Business Daily

Marijuana company involved in Missouri’s huge recall loses final license appeal

Published

6 days ago

February 21, 2025

admin

Missouri marijuana processor Delta Extraction has lost its final appeal, resulting in the termination of its business license after its role in a massive 2023 product recall.

According to the Missouri Independent, the state’s Administrative Hearing Commission this week upheld an earlier decision by state regulators who suspended Delta Extraction’s marijuana business license in August 2023, accusing the company of sourcing materials from an unlicensed facility.

The commission essentially agreed with the Division of Cannabis Regulation (DCR) that Delta Extraction violated Missouri law by infusing products with THCA sourced from outside the state.

In a 137-page ruling issued Tuesday, the Administrative Hearing Commission said the company had a “corporate culture of lax compliance with regulatory requirements,” the Independent reported.

An attorney representing

Read full article on Marijuana Business Daily

Source link